Oxfordshire company is playing a key COVID-19 role delivering vital supplies to new NHS hospitals

April 2, 2020 |

2nd April 2020, Oxford – Owen Mumford, a leading Oxfordshire-based medical device company, is making a difference by supporting the NHS’s effort to tackle COVID-19. The company has supplied the NHS with more than 10 million finger-pricking devices to stock the regional Nightingale field hospitals, the first of which will receive patients from this week at London Excel.

Owen Mumford manufactures the finger-pricking devices, known as Unistik® safety lancets in Woodstock, for rapid blood testing for conditions such as diabetes and HIV and regularly supplies the NHS. However, the company has pulled out all the stops to fulfil this extraordinary NHS request, which it is understood will provide critical supplies for the new medical facilities being set up across the country.

Jarl Severn, Managing Director of Owen Mumford says, “We are glad to be able to play a part in the management of the COVID-19 crisis and I’m grateful to our team for their agility in turning around the production so quickly.

At the same time, we are continuing to produce injection devices, including pens and auto-injectors, to supply patients with conditions such as rheumatoid arthritis, multiple sclerosis and diabetes as well as the lifesaving Anapen devices for anaphylactic shock for people with extreme allergic reactions. We understand that many will be relying on having access to these devices to enable them to receive and self-medicate with essential medicines throughout the National lockdown period.”

Joanne Thompson, General Manager UK & Ireland and Rest of the World (ROW) is based at Owen Mumford’s site in Chipping Norton and has worked for the company for 18 years. She comments, “We understand the importance of supplying the NHS with the medical devices it needs to treat patients while tackling this crisis. Our production and supply teams have worked very hard to get this order out quickly. We are all aware of the crucial role that these devices will play and feel very proud that, in our own way, we are making a difference to the medical profession’s bid to combat the virus.”

In addition to the direct NHS lancet orders, Owen Mumford is working with the developers of COVID-19 rapid diagnostic tests. This is the second wave of tests that involve blood samples to test for antibodies, initially for critical care workers. The first orders have already been shipped to sites across the UK and the team in Oxfordshire will continue to support demand as the crisis develops.